Back to top
more

Pacer BioThreat Strategy ETF: (VIRS)

(Delayed Data from NYSE MKT (ex. AMEX)) As of May 19, 2022 03:50 PM ET

 Add to portfolio

$27.55 USD

27.5469
1,600

+0.20 (0.72%)

Volume: 1,600

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 27.55
Open 27.66
Bid 14.60
Ask 2,147.48
Day Low-High 27.54-27.68
52wk Low-High 27.20-35.32
Volume 1,600
NAV (month end) 28.51
Premium (+)/Discount (-) (month end)-0.96

Zacks Premium Research for VIRS

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.70%
Dividend (Yield) $0.24 (0.86%)
Issuer PACER ETFS

Benchmark for VIRS

LIFESCI BIOTHREAT STRATEGY INDEX

The LifeSci BioThreat Strategy Index comprises of U.S. listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health.

Fund Summary for VIRS

PACER BIOTHREAT STRATEGY ETF

The Pacer BioThreat Strategy ETF seeks to track the performance, before fees and expenses, of the LifeSci BioThreat Strategy Index.